Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin-containing Regimen for Recurrent Pulmonary Tuberculosis
NCT02114684Phase 2Completed
- Sponsor
- CAPRISA
- Start
- Nov 2013
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of moxifloxacin in pulmonary tuberculosis (TB), sponsored by CAPRISA. Started Nov 2013; status: completed.
02
Drugs
moxifloxacin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02114684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02114684.